CellPoint
Oegstgeest
About CellPoint
CellPoint is dedicated to developing CAR-T therapies at the point of care, making these therapies more affordable and accessible to patients. CellPoint has developed a 6-day manufacturing process, powered by its proprietary xCellit real-time monitoring software system, that allows for 1 week of vein-to-vein time compared to over one month with current industrial manufacturing platforms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Website: cellpoint.bio
- Phone: +31 712077810
Social Profiles
Canonical: https://fsome.com/organization/cellpoint-3208713 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.